PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
3 January 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

TOP 10 NEWS OF 2017

EMA to Relocate to New HQ in Amsterdam in Wake of Brexit

Following a vote by member states in favour of Amsterdam as the agency's new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
/ read more /


FDA to Recognize Inspections from EU Drug Authorities

A mutual recognition agreement to accept inspection data from eight EU regulatory authorities may reduce inspection burdens at global drug facilities.
/ read more /

advertisement

Catalent to Acquire Cook Pharmica for $950 Million

The acquisition adds to Catalent's capabilities in biologics development, analytical services, manufacturing, and finished product supply.
/ read more /


EMA Updates Brexit Guidance

The agency and the European Commission published updated guidance to answer questions about Brexit.
/ read more /


EU Suspends Modified-Release Products with Paracetamol

EMA recommends suspending the marketing of modified- or prolonged-released products containing paracetamol due to a difficulty in managing overdose.
/ read more /


EMA Looks at Drug Development for Senior Population

The agency is asking for comments on a reflection paper on developing drugs for the needs of older patients.
/ read more /

EDQM Releases Annual Report

The report emphasizes the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.) and the efforts made in global harmonization of standards and regulations throughout and beyond the European Union.
/ read more /


EMA Approves Janssen Drug Made Via Continuous Manufacturing

EMA has approved Prezista (darunavir) made via a continuous manufacturing process at Janssen's facility in Puerto Rico.
/ read more /


EMA Suspends Drugs Associated with Micro Therapeutic Research Labs

The agency is recommending the suspension of a variety of medications because of unreliable bioequivalence studies conducted by Micro Therapeutic Research Labs.
/ read more /


Europe Updates Elemental Impurities Strategy

EDQM outlines the steps it will take to implement the ICH Q3D guideline on elemental impurities.
/ read more /


TOP FEATURES OF 2017

Establishing Blend Uniformity Acceptance Criteria for Oral Solid-Dosage Forms

This article introduces the concepts of pooled variance and the central limit theorem, which are intended for establishing acceptance criteria for blend uniformity data of granular powder blends when a significant degree of sampling bias is involved.
/ read more /


Key Considerations in Capsule Filling

Capsule filling is a complex process, and the product to be encapsulated must be well developed to ensure mass uniformity.
/ read more /


Designing Optimized Formulations

Design of experiment plays a crucial role in the optimization process of formulation development.
/ read more /


Comparison of Permitted Daily Exposure with 0.001 Minimal Daily Dose for Cleaning Validation

In this study, the authors investigated the relationship between the 0.001 MinDD and the PDE values for 140 drug substances as an attempt to identify high-risk groups of products for patient safety. This comparison can serve as a method for prioritization of APIs for development of PDEs.
/ read more /

 

PAT for Continuous API Manufacturing Progresses

Advances in process analytical technology have been achieved, but significant challenges remain.
/ read more /


Evaluating Progress in Analytical Quality by Design

The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.
/ read more /


Understanding Dissolution Testing

Industry experts discuss best practices for dissolution testing of poorly soluble, immediate-release, and controlled-release formulations and the different analytical approaches used.
/ read more /


Oral Delivery of Biologic APIs: The Challenge Continues

Effective solutions for overcoming the high molecular weight, hydrophilicity, and instability of large biomolecules have yet to be identified.
/ read more /


Event Profile

Pharmapack Europe

Date: 7 & 8 February 2018
Venue: Paris Expo, Porte de Versailles, Paris
The event to showcase evolution and revolution in packaging and drug delivery
Pharmapack Europe is an essential event for industry insights and the latest industry innovations that are reimagining the capabilities of pharmaceutical packaging and drug delivery. Join 411 exhibitors and more than 5,290 attendees on 7 & 8 February at Paris Expo, Porte de Versailles!
/ Read more/


LIVE WEBCAST

Considerations for Launching a Biopharm Company in 2018
Live Webcast: Monday, January 8 at 10:00am EST
Register now


ON DEMAND WEBCASTS

The Journey to a Successful Biologic License Application
On Demand
Learn more


Risk Assessment and Testing Requirements for Elemental Impurities in Pharmaceutical Products
On Demand
Learn more


Events

Pharmapack Europe

Paris, France

7–8 February 2018

9th Global Drug Delivery & Formulation Summit

Berlin, Germany

12–14 March 2018

Paperless Lab Academy 2018

Milano, Italy

20–21 March 2018


more events

eBOOKS

Vaccines Development and Manufacturing 2017

New technologies, including single-use systems, are leading the push for faster production and higher titers. At the same time, ensuring quality in raw materials and water systems, and controlling contamination are paramount. In this Biologics and Sterile Manufacturing eBook, the editors explore key technology, process, and operational topics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise